Assessing Past FDA Inspection Outcomes for PIs
Assessing Past FDA Inspection Outcomes for PIs How to Evaluate Past FDA Inspection Outcomes When Selecting Principal Investigators Introduction: Why PI Inspection History Matters Past performance is often the best predictor of future risk. In clinical trials, one of the most critical factors during site feasibility is the Principal Investigator’s (PI) history with regulatory inspections—particularly…
Read More “Assessing Past FDA Inspection Outcomes for PIs” »
